Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation.
Kiely AP, Ling H, Asi YT, Kara E, Proukakis C, Schapira AH, Morris HR, Roberts HC, Lubbe S, Limousin P, Lewis PA, Lees AJ, Quinn N, Hardy J, Love S, Revesz T, Houlden H, Holton JL.
Kiely AP, et al. Among authors: asi yt.
Mol Neurodegener. 2015 Aug 27;10:41. doi: 10.1186/s13024-015-0038-3.
Mol Neurodegener. 2015.
PMID: 26306801
Free PMC article.